REVER vs Kenvue

Side-by-side comparison of AI visibility scores, market position, and capabilities

Kenvue leads in AI visibility (94 vs 32)
REVER logo

REVER

EmergingE-commerce

General

E-commerce returns platform providing instant refunds at return initiation; YC and Sequoia-backed serving 130+ retailers competing with Loop Returns for returns management in Europe.

AI VisibilityBeta
Overall Score
D32
Category Rank
#364 of 1158
AI Consensus
82%
Trend
up
Per Platform
ChatGPT
23
Perplexity
30
Gemini
25

About

REVER is an e-commerce returns management platform that provides instant cash refunds to online shoppers at the moment of return initiation — rather than making customers wait weeks for their money back after shipping a return — while simultaneously automating label generation and the full returns processing workflow for retailers. Founded in 2022 in Barcelona, Spain and backed by Y Combinator and Sequoia Capital with €7.5 million in funding, REVER serves 130+ customers with a 35-person team, recognized among the top 10 fastest-growing Spanish startups by EU-Startups.\n\nREVER's business model works like a returns buy-now-pay-later: when a customer initiates a return, REVER immediately deposits the refund into the customer's account, then processes the physical return and collects reimbursement from the retailer. This eliminates the worst part of online shopping returns — the waiting period where customers have neither their money nor their product. For retailers, REVER automates the return label generation, logistics routing, item inspection, and refund reconciliation that manual returns processing requires, while the instant refund improves customer satisfaction scores.\n\nIn 2025, REVER competes in the e-commerce returns management market with Loop Returns (the leading Shopify returns management platform), Happy Returns (UPS-owned), Narvar, and Returnly for returns processing automation. Returns represent 15-30% of all e-commerce purchases, making returns management a significant operational cost and customer experience driver for online retailers. REVER's instant refund differentiator addresses the customer satisfaction gap that competitors with standard "refund when received" policies haven't closed. The 2025 strategy focuses on growing with European e-commerce retailers, expanding the instant refund product to more markets, and adding analytics that help retailers reduce return rates through better product information.

Full profile
Kenvue logo

Kenvue

LeaderConsumer Goods

Enterprise

Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.

AI VisibilityBeta
Overall Score
A94
Category Rank
#31 of 290
AI Consensus
70%
Trend
stable
Per Platform
ChatGPT
91
Perplexity
99
Gemini
89

About

Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).

Full profile

AI Visibility Head-to-Head

32
Overall Score
94
#364
Category Rank
#31
82
AI Consensus
70
up
Trend
stable
23
ChatGPT
91
30
Perplexity
99
25
Gemini
89
27
Claude
93
23
Grok
86

Key Details

Category
General
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.